HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Koide Selected Research

candesartan cilexetil (Amias)

9/2002Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes.
11/2000Effects of the angiotensin II receptor antagonist candesartan cilexetil on blood pressure and proteinuria in patients with autosomal dominant polycystic kidney disease.
10/2000Comparison between the angiotensin II receptor antagonist candesartan cilexetil and the angiotensin-converting enzyme inhibitor trandolapril in microalbuminuria of patients with early diabetic nephropathy.
9/2000Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Koide Research Topics

Disease

9Diabetic Nephropathies (Diabetic Nephropathy)
11/2008 - 08/2000
6Sepsis (Septicemia)
01/2003 - 01/2000
5Type 2 Diabetes Mellitus (MODY)
09/2002 - 09/2000
4Proteinuria
06/2004 - 09/2000
4IGA Glomerulonephritis (IGA Nephropathy)
05/2001 - 07/2000
3Neoplasms (Cancer)
07/2020 - 05/2000
3Lupus Nephritis
02/2002 - 08/2000
2Hyperlipidemias (Hyperlipidemia)
09/2009 - 06/2004
2Inflammation (Inflammations)
09/2009 - 01/2000
2Ischemia
11/2008 - 06/2004
2Chronic Kidney Failure (Chronic Renal Failure)
02/2007 - 05/2000
2Nephrotic Syndrome (Syndrome, Nephrotic)
01/2006 - 06/2004
2Dyslipidemias (Dyslipidemia)
11/2001 - 11/2001
2Autosomal Dominant Polycystic Kidney (ADPKD)
05/2001 - 11/2000
1Colonic Neoplasms (Colon Cancer)
07/2020
1Fibrosarcoma
02/2015
1Obesity
09/2009
1Atherosclerosis
09/2009
1Body Weight (Weight, Body)
01/2006
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2006
1Skin Ulcer
06/2004
1Hypesthesia (Numbness)
06/2004
1Hypoalbuminemia
06/2004
1Pain (Aches)
06/2004
1Arteriosclerosis Obliterans
06/2004
1Hypertension (High Blood Pressure)
07/2003
1Autoimmune Diseases (Autoimmune Disease)
02/2002
1Respiratory Insufficiency (Respiratory Failure)
11/2001
1Poisoning
11/2001
1Insulin Resistance
10/2001
1Albuminuria
04/2001
1Rhabdomyolysis
10/2000
1Acute Kidney Injury (Acute Renal Failure)
10/2000
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2000

Drug/Important Bio-Agent (IBA)

6Polymyxin B (Aerosporin)FDA LinkGeneric
01/2003 - 01/2000
5Angiotensin Receptor AntagonistsIBA
11/2008 - 09/2000
5Endothelins (Endothelin)IBA
07/2003 - 03/2000
5AlbuminsIBA
09/2002 - 09/2000
4candesartan cilexetil (Amias)FDA Link
09/2002 - 09/2000
3CreatinineIBA
06/2004 - 09/2000
3Endothelin-1 (Endothelin 1)IBA
09/2002 - 03/2000
3trandolapril (Mavik)FDA LinkGeneric
09/2002 - 09/2000
3Pioglitazone (Actos)FDA Link
11/2001 - 09/2000
3Collagen Type IV (Type IV Collagen)IBA
11/2001 - 01/2000
3Tissue Inhibitor of Metalloproteinase-1IBA
11/2001 - 01/2000
3DilazepIBA
05/2001 - 07/2000
2Pharmaceutical PreparationsIBA
07/2020 - 01/2006
2Fatty Acid-Binding ProteinsIBA
02/2007 - 01/2006
2oxidized low density lipoproteinIBA
01/2006 - 06/2004
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2006 - 06/2004
2SteroidsIBA
02/2002 - 08/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2002 - 02/2001
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2001 - 08/2000
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2000 - 09/2000
1Retinoblastoma ProteinIBA
07/2020
1Positive Regulatory Domain I-Binding Factor 1IBA
07/2020
1Biological ProductsIBA
02/2015
1AgarIBA
02/2015
1Transcription Factors (Transcription Factor)IBA
02/2015
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2009
1Retinoid X Receptor alphaIBA
09/2009
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2009
1AntioxidantsIBA
11/2008
1azelnidipineIBA
11/2008
1glycocyamineIBA
01/2006
1Glucose (Dextrose)FDA LinkGeneric
01/2006
1Indicators and Reagents (Reagents)IBA
01/2006
1Streptozocin (Streptozotocin)FDA Link
01/2006
1Proteins (Proteins, Gene)FDA Link
06/2004
1ErythropoietinFDA Link
07/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2003
1TeicoplaninIBA
01/2003
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
09/2002
1AngiotensinsIBA
09/2002
1AutoantibodiesIBA
02/2002
1Antigen-Antibody Complex (Immune Complex)IBA
02/2002
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2001
1HDL CholesterolIBA
11/2001
1LDL CholesterolIBA
11/2001
1ParaquatIBA
11/2001
1Triglycerides (Triacylglycerol)IBA
11/2001
1CholesterolIBA
11/2001
1cerivastatin (Kazak)FDA Link
11/2001
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2001
12,4-thiazolidinedione (thiazolidinedione)IBA
04/2001
1Troglitazone (Rezulin)FDA Link
04/2001
1mizoribineIBA
02/2001
1Azathioprine (Imuran)FDA LinkGeneric
02/2001
1Immunoglobulin E (IgE)IBA
02/2001
1Phosphates (Orthophosphate)IBA
11/2000
1Verapamil (Calan)FDA LinkGeneric
09/2000
1CalciumIBA
09/2000
1Antihypertensive Agents (Antihypertensives)IBA
09/2000
1Immunoglobulin A (IgA)IBA
09/2000
1Glyburide (Glibenclamide)FDA LinkGeneric
09/2000

Therapy/Procedure

7Therapeutics
11/2008 - 01/2000
6Renal Dialysis (Hemodialysis)
07/2003 - 01/2000
2Blood Component Removal (Apheresis)
01/2006 - 06/2004
2Hemoperfusion
10/2000 - 08/2000
1Plasmapheresis
02/2002